Summary
The prevalence of serological markers for present and past hepatitis B virus (HBV) infection and antibodies against cytomegalovirus (CMV) among Norwegians with coagulation factor defects was examined in serum samples collected before virus-inactivated coagulation concentrates came into use. Sera collected in 1985/86 from 324 of 377 (86%) registered persons with such defects were available. Three persons were chronic carriers of HBsAg. The prevalence of HBV antibodies was 28% compared with about 5% in the general population. The highest prevalence rate was found among patients with severe haemophilia A (44%) and in patients with haemophilia B (39%). The prevalence of anti-CMV antibodies was 75% which is similar to that found in the general Norwegian population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cheeseman S, Sullivan JL, Brattler DR, Levine PH (1984) Analysis of cytomegalovirus and Epstein-Barr virus antibody response in treated hemophiliacs. JAMA 252: 83–85
Evatt BL, Gomperts ED, McDougal JS, Ramsey MS (1985) Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the epidemic. N Engl J Med 312: 483–486
Evensen SA, Ulstrup J, Skaug K, Frøland SS, Glomstein A, Rollag H (1987) HIV infection in Norwegian haemophiliacs: The prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors. Eur J Haematol 39: 44–48
Helske T (1974) Carriers of hepatitis B antigen and transfusion hepatitis in Finland. Scand J Haematol [Suppl 23]
Hurlen B, Jonsen J, Aas E (1980) Viral hepatitis in denstists in Norway. Acta Odontol Scand 38: 321–324
Klose HJ (1982) Hepatitis als Schicksal des Hämophiliepatienten. In: Frösner G, Lasch H-G, Lechler E (eds) Plasmaproteine und Virushepatitis. Springer, Berlin Heidelberg New York, pp 24–32
Montif GRG, Daicoff GI, Flory LF (1976) Blood as a potential vehicle for the cytomegalovirus. Am J Obstet Gynecol 126: 445–448
Rickard KA, Dority P, Campbell J, Batey RG, Johnson S, Hudgson J (1982) Hepatitis and haemophilia therapy in Australia. Lancet II: 146–148
Schiller WG, Gärtner L, Oberender H, Remde W, Rehfeld B (1984) Epstein-Barr-Virus- und Zytomegalievirus-Antikörper bei Kindern und Jugendlichen mit hämophilen Gerinnungsstörungen. Deutsch Gesundheitswesen 39: 1906–1909
Skar AG, Hoddevik G (1984) Prevalence of cytomegalovirus in Norwegian kidney transplant recipients and their living donors. Acta Pathol Microbiol Scand Sect B 92: 1–5
Stein SF, Evatt BL, McDougal EJ, Lawrence DH, Holman RC, Ramsey RB, Spira TJ (1985) A longitudinal study of patients with hemophilia. Immunologic correlates of infection with HTLV-III/LAV and other viruses. Blood 66: 973–979
Tabor E, Purcell RH, London WT, Gerety RJ (1983) Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J Inf Dis 147: 531–534
The AIDS-Hemophilia French study group (1985) Immunologic and virologic status of multi-transfused patients: Role of type and origin of blood products. Blood 66: 896–901
Ulstrup JC, Figenschou KJ (1972) Frequency of hepatitis B infections. Lancet II: 1035
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rollag, H., Evensen, S.A., Frøland, S.S. et al. Serological markers of hepatitis B virus and cytomegalovirus infections in Norwegians with coagulation factor defects. Blut 60, 93–96 (1990). https://doi.org/10.1007/BF01720514
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01720514